H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 122 Citations 58,800 726 World Ranking 1412 National Ranking 4

Research.com Recognitions

Awards & Achievements

2005 - Member of the National Academy of Sciences

2001 - Fellow, The World Academy of Sciences

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

His primary areas of investigation include Hepatitis B virus, Immunology, Virology, Hepatocellular carcinoma and Hepatitis B. The concepts of his Hepatitis B virus study are interwoven with issues in Pediatrics and Viral load. He has included themes like Transmission, Liver disease and Genotype in his Immunology study.

His Hepatocellular carcinoma study is focused on Internal medicine in general. His research on Hepatitis B also deals with topics like

  • Vaccination, which have a strong connection to Hepatitis B vaccine,
  • Young adult most often made with reference to Cohort. His studies in HBsAg integrate themes in fields like Antibody and Antigen.

His most cited work include:

  • Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. (1481 citations)
  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (1023 citations)
  • Hepatitis B e antigen and the risk of hepatocellular carcinoma. (995 citations)

What are the main themes of his work throughout his whole career to date?

Ding-Shinn Chen mainly investigates Virology, Hepatitis B virus, Immunology, Internal medicine and Gastroenterology. His Virology study frequently intersects with other fields, such as Genotype. His Hepatitis B virus research incorporates themes from Hepatitis B and Hepatocellular carcinoma.

The Hepatitis B study combines topics in areas such as Viral hepatitis, Hepatitis B vaccine and Pediatrics. His work carried out in the field of Hepatocellular carcinoma brings together such families of science as Liver disease, Carcinoma, Pathology and Radiology. He interconnects Chronic hepatitis and Ribavirin in the investigation of issues within Internal medicine.

He most often published in these fields:

  • Virology (42.97%)
  • Hepatitis B virus (38.71%)
  • Immunology (35.14%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (37.44%)
  • Hepatitis B virus (38.71%)
  • Gastroenterology (27.07%)

In recent papers he was focusing on the following fields of study:

Ding-Shinn Chen mostly deals with Internal medicine, Hepatitis B virus, Gastroenterology, Virology and Hepatitis C virus. His work in Internal medicine addresses subjects such as Ribavirin, which are connected to disciplines such as NS5A and Combination therapy. His studies deal with areas such as Hepatitis B and Viral load as well as Hepatitis B virus.

His study focuses on the intersection of Hepatitis B and fields such as Vaccination with connections in the field of Immunization. In Virology, Ding-Shinn Chen works on issues like Liver disease, which are connected to Hepatology. His Hepatitis C virus research includes themes of Coinfection and Kidney disease.

Between 2013 and 2021, his most popular works were:

  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (1023 citations)
  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study (436 citations)
  • The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo (263 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

Ding-Shinn Chen spends much of his time researching Hepatitis B, Hepatitis B virus, Internal medicine, Immunology and HBsAg. The various areas that he examines in his Hepatitis B study include Hepatitis B vaccine, Incidence, Viral hepatitis, Hepatocellular carcinoma and Vaccination. Ding-Shinn Chen is conducting research in Virology and Virus as part of his Hepatitis B virus study.

His Internal medicine research integrates issues from Gastroenterology and Ribavirin. His Immunology research focuses on subjects like Cohort, which are linked to Young adult and Case-control study. The study incorporates disciplines such as Entecavir, Lower risk and Pediatrics in addition to HBsAg.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

Mei-Hwei Chang;Chien-Jen Chen;Mei-Shu Lai;Hsu-Mei Hsu.
The New England Journal of Medicine (1997)

2343 Citations

Hepatitis B e antigen and the risk of hepatocellular carcinoma.

Hwai I. Yang;Sheng Nan Lu;Yun Fan Liaw;San Lin You.
The New England Journal of Medicine (2002)

1531 Citations

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas.
Hepatology International (2016)

1436 Citations

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

Jia-Horng Kao;Pei-Jer Chen;Ming-Yang Lai;§ Ding-Shinn Chen‡.
Gastroenterology (2000)

1380 Citations

A proposed system for the nomenclature of hepatitis C viral genotypes

Peter Simmonds;Alfredo Alberti;Harvey J. Alter;Ferruccio Bonino.
Hepatology (1994)

1287 Citations

Global control of hepatitis B virus infection

Jia-Horng Kao;Ding-Shinn Chen.
Lancet Infectious Diseases (2002)

1100 Citations

Statements from the Taormina expert meeting on occult hepatitis B virus infection.

Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia.
Journal of Hepatology (2008)

987 Citations

Hepatitis B genotypes and the response to interferon therapy.

Jia-Horng Kao;Nan-Hui Wu;Pei-Jer Chen;Ming-Yang Lai.
Journal of Hepatology (2000)

728 Citations

Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men

Ming-Whei Yu;Shiou-Hwei Yeh;Pei-Jer Chen;Yun-Fan Liaw.
Journal of the National Cancer Institute (2005)

727 Citations

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

Hwai I. Yang;Shiou Hwei Yeh;Pei Jer Chen;Pei Jer Chen;Uchenna H. Iloeje.
Journal of the National Cancer Institute (2008)

679 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ding-Shinn Chen

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 204

Masashi Mizokami

Masashi Mizokami

Nagoya City University

Publications: 174

Chien-Jen Chen

Chien-Jen Chen

Academia Sinica

Publications: 153

Man-Fung Yuen

Man-Fung Yuen

University of Hong Kong

Publications: 152

Ching-Lung Lai

Ching-Lung Lai

University of Hong Kong

Publications: 142

Pei-Jer Chen

Pei-Jer Chen

National Taiwan University

Publications: 132

Mei-Hwei Chang

Mei-Hwei Chang

National Taiwan University

Publications: 131

Shou-Dong Lee

Shou-Dong Lee

Taipei Veterans General Hospital

Publications: 123

Yasuhito Tanaka

Yasuhito Tanaka

Nagoya University

Publications: 123

Henry Lik-Yuen Chan

Henry Lik-Yuen Chan

Chinese University of Hong Kong

Publications: 109

Fabien Zoulim

Fabien Zoulim

Inserm : Institut national de la santé et de la recherche médicale

Publications: 104

Stephen Locarnini

Stephen Locarnini

Melbourne Health

Publications: 91

Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Chinese University of Hong Kong

Publications: 89

Mengji Lu

Mengji Lu

University of Duisburg-Essen

Publications: 87

Harry L.A. Janssen

Harry L.A. Janssen

University Health Network

Publications: 85

Kwang Hyub Han

Kwang Hyub Han

Yonsei University

Publications: 85

Something went wrong. Please try again later.